Showing results (5281-5290 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|February 24, 2018
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)Germán Reyes-Botero, Stéphanie Cartalat-Carel, Olivier L Chinot, et al.
The Oncologist|March 18, 2020
Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and ValidationYijiao Chen, Wenju Chang, Li Ren, et al.
The Oncologist|January 28, 2020
A Randomized Trial of Real-Time Geriatric Assessment Reporting in Nonelectively Hospitalized Older Adults with CancerTrevor A Jolly, Allison M Deal, Caroline Mariano, et al.
The Oncologist|September 5, 2014
Genome-based risk prediction for early stage breast cancerChristina Adaniel, Komal Jhaveri, Adriana Heguy, et al.
The Oncologist|September 5, 2014
How to implement a geriatric assessment in your clinical practiceSchroder Sattar, Shabbir M H Alibhai, Hans Wildiers, et al.
The Oncologist|July 9, 2014
Radiation therapy for liver tumors: ready for inclusion in guidelines?Shyam K Tanguturi, Jennifer Y Wo, Andrew X Zhu, et al.
The Oncologist|August 22, 2014
Age-specific changes in intrinsic breast cancer subtypes: a focus on older womenEmily O Jenkins, Allison M Deal, Carey K Anders, et al.
The Oncologist|June 30, 2016
The Future of Immunotherapy in the Treatment of Small Cell Lung CancerLeora Horn, Martin Reck, David R Spigel
The Oncologist|May 7, 2016
Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and ManagementKhurum H Khan, Mabel Wong, Karim Rihawi, et al.
The Oncologist|June 17, 2016
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse EventsElisa González-Rodríguez, Delvys Rodríguez-Abreu,
Pageof 571